Portland, ORNCT07432490Now EnrollingIRB Ready

Glut1 Deficiency Clinical Trial in Portland, OR

Access cutting-edge glut1 deficiency treatment through this clinical trial at a research site in Portland. Study-provided care at no cost to qualified participants.

Sponsored by Oregon Health and Science University

Quick Self-Assessment

See if you qualify for this Portland location

Preparing your pre-screening questions…

Expert Care in Portland

Access glut1 deficiency specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related glut1 deficiency treatment provided free

Apply for This Portland Location

Check if you qualify for this glut1 deficiency clinical trial in Portland, OR

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Portland

    Convenient for OR residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Portland site if eligible
  4. 4Begin participation

About This Glut1 Deficiency Study in Portland

This is a single-center, randomized, double-blind, placebo-controlled, cross-over study to evaluate the efficacy and safety of L-fucose supplementation in subjects with GLUT1 deficiency syndrome (GLUT1DS).

Sponsor: Oregon Health and Science University

Who Can Participate

Inclusion Criteria

Age ≥ 18 years
Confirmed diagnosis of GLUT1DS, including at least 2 out of the following 3: molecular genetic testing showing a pathogenic or likely pathogenic variant in SLC2A1; documented hypoglycorrhachia with a CSF:blood glucose ratio ≤ 0.6; clinical features consistent with GLUT1DS (epilepsy, movement disorders, ataxia, intellectual disability, dysarthria)
Presence of ataxia

Exclusion Criteria

Inability to swallow liquids
Change in neurological medications (either medication itself or medication dosages) in the past 90 days
Use of fucose- or mannose-containing supplements within one year of enrollment
Presence of hepatic, renal, hematological, or concomitant metabolic disorders, as assessed by the presence of a previous diagnosis of such disorders (for instance, chronic kidney disease, liver cirrhosis, diabetes mellitus) or by the following laboratory values, which will be considered if obtained clinically up to 90 days before enrollment (if this is not available, laboratory tests will be obtained prior to first study visit):
Any degree of hepatic impairment based on the Child-Pugh classification
eGFR (as measured by serum creatinine or cystatin C) \< 60 mg/min/1.73m2
Hemoglobin A1c \> 6.5%
Hemoglobin level below the lower limit of normal (LLN) for sex and age
Platelet counts below the LLN for sex and age
Subjects who are pregnant, breastfeeding, or planning to become pregnant within one year of enrollment
Enrollment in an investigational new drug trial for G1DS within one year of enrollment

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Portland?

Yes, this clinical trial (NCT07432490) has an active research site in Portland, OR that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Glut1 Deficiency Treatment Options in Portland, OR

If you're searching for glut1 deficiency treatment options in Portland, OR, this clinical trial (NCT07432490) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Portland research site is actively enrolling participants for this clinical trial. You'll receive care from experienced glut1 deficiency specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all glut1 deficiency clinical trials near you to find additional studies recruiting in your area.

More Interstitial Cystitis Trials in Portland, OR

See all interstitial cystitis clinical trials recruiting in Portland — not just this study.

Browse Interstitial Cystitis Trials in Portland →

Browse More Trials by Condition

Interstitial Cystitis TrialsAll Conditions →

Ready to Join in Portland?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Portland, OR